Extended-release naltrexone opioid treatment at jail reentry (XOR)

BACKGROUND: Extended-release naltrexone (XR-NTX) is an injectable monthly sustained-release mu opioid receptor antagonist, which blocks the typical effects of heroin and other opioid agonists. Use of XR-NTX among opioid dependent persons leaving jails and prisons is increasing despite scant high-qua...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Contemp Clin Trials
Main Authors: McDonald, Ryan D., Tofighi, Babak, Laska, Eugene, Goldfeld, Keith, Bonilla, Wanda, Flannery, Mara, Santana-Correa, Nadina, Johnson, Christopher W., Leibowitz, Neil, Rotrosen, John, Gourevitch, Marc N., Lee, Joshua D.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455014/
https://ncbi.nlm.nih.gov/pubmed/27178765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2016.05.002
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares